Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mirabel Meds vs VyrarX

Mirabel Meds
Graded #397

Lower grade

vs+10.799999999999997
VyrarX
Graded #156

Higher grade

The verdict

VyrarX takes it — 68.3/100 to 57.5/100.

VyrarX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVyrarX +15
45
60
Dose & formulationVyrarX +24
40
64
Clinical oversightVyrarX +5
79
84
Labs & monitoringVyrarX +18
54
72
FulfillmentMirabel Meds +12
83
71
Contract termsEven
55
55
Mirabel Meds · left barVyrarX · right bar

The numbers

MetricMirabel MedsVyrarX
WeighScore57.5/10068.3/100
GradeCC
Scorecard rank#397#156
SemaglutideNot disclosed$179/mo (starting dose, compounded)
TirzepatideNot disclosed$329/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mirabel Meds

Graded #397 · C

Strengths

  • LegitScript certified with board-certified Internal Medicine physician oversight
  • Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
  • White-glove concierge — direct provider messaging, no automated bots
  • Cold-chain temperature-controlled delivery to all 50 states
  • Monthly clinical reviews and dose adjustments included with every plan

Where it loses points

  • Pricing not publicly disclosed — requires a consultation to receive a quote
  • Compounded medications are not FDA-approved individual drugs
  • No named pharmacy partner disclosed on public pages
  • Labs not mentioned on any public page — baseline bloodwork protocol unknown
  • Concierge positioning suggests premium pricing above market average
VyrarX

Graded #156 · C

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where it loses points

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard